LeMaitre Vascular
LMAT
243 hedge funds and large institutions have $1.34B invested in LeMaitre Vascular in 2024 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 86 increasing their positions, 88 reducing their positions, and 21 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
81% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 21
16% more capital invested
Capital invested by funds: $1.16B → $1.34B (+$188M)
7% more funds holding
Funds holding: 227 → 243 (+16)
0.8% less ownership
Funds ownership: 91.55% → 90.75% (-0.8%)
2% less repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 88
71% less call options, than puts
Call options by funds: $796K | Put options by funds: $2.71M
Top Buyers
| 1 |
Millennium Management
New York
|
+$5.81M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4.73M |
| 3 |
CAM
Congress Asset Management
Boston,
Massachusetts
|
+$4.41M |
| 4 |
BlackRock
New York
|
+$3.49M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$2.91M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$18.2M |
| 2 |
RIM
Ranger Investment Management
Dallas,
Texas
|
-$5.48M |
| 3 |
CRM
Cramer Rosenthal McGlynn
Stamford,
Connecticut
|
-$4.74M |
| 4 |
Two Sigma Investments
New York
|
-$2.56M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$2.37M |
LMAT Hedge Fund Activity: Q1 2024 in Review
243 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in LeMaitre Vascular (LMAT) for Q1 2024, worth a combined $1.34B — up 16% from $1.16B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new LMAT positions and 21 closed out — a net gain of 17 holders — while 86 added to existing stakes and 88 trimmed.
The largest buyer was Millennium Management, adding an estimated $5.81M. The largest seller was Morgan Stanley, cutting an estimated $18.2M.
- 243 institutional investors held LeMaitre Vascular (LMAT) as of Q1 2024, up from 227 in Q4 2023.
- Funds reported $1.34B of LeMaitre Vascular stock for Q1 2024, up 16% quarter-over-quarter.
- 38 funds opened new LeMaitre Vascular positions in Q1 2024 and 21 closed out, a net change of +17 holders.
- The largest LeMaitre Vascular buyer in Q1 2024 was Millennium Management, an estimated $5.81M added.
- The largest LeMaitre Vascular seller in Q1 2024 was Morgan Stanley, an estimated $18.2M sold.
Based on aggregated 13F filings for Q1 2024.